Cargando…
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
BACKGROUND: Cardiac magnetic resonance (CMR) can quantify myocardial infarct (MI) size and myocardium at risk (MaR), enabling assessment of myocardial salvage index (MSI). We assessed how MSI impacts the number of patients needed to reach statistical power in relation to MI size alone and levels of...
Autores principales: | Engblom, Henrik, Heiberg, Einar, Erlinge, David, Jensen, Svend Eggert, Nordrehaug, Jan Erik, Dubois‐Randé, Jean‐Luc, Halvorsen, Sigrun, Hoffmann, Pavel, Koul, Sasha, Carlsson, Marcus, Atar, Dan, Arheden, Håkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943247/ https://www.ncbi.nlm.nih.gov/pubmed/26961520 http://dx.doi.org/10.1161/JAHA.115.002708 |
Ejemplares similares
-
Design of clinical cardioprotection trials using CMR: impact of myocardial salvage index and a narrow inclusion window on sample size
por: Engblom, Henrik, et al.
Publicado: (2015) -
The extent of myocardium at risk for LAD, RCA and LCx using contrast enhanced SSFP and T2-weighted imaging
por: Nordlund, David, et al.
Publicado: (2015) -
Infarct size is overestimated by contrast-enhanced CMR in the acute phase but not at 7 days when compared with histopathology
por: Jablonowski, Robert, et al.
Publicado: (2014) -
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
por: Seemann, Felicia, et al.
Publicado: (2017) -
Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trials
por: Nordlund, David, et al.
Publicado: (2015)